- $381.06bn
- $432.39bn
- $400.28bn
- 68
- 60
- 22
- 49
Annual income statement for Unitedhealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Other Revenue | |||||
Total Revenue | 257,141 | 287,597 | 324,162 | 371,622 | 400,278 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 234,736 | 263,627 | 295,727 | 339,264 | 376,301 |
Operating Profit | 22,405 | 23,970 | 28,435 | 32,358 | 23,977 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 20,742 | 22,310 | 26,343 | 29,112 | 20,071 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15,769 | 17,732 | 20,639 | 23,144 | 15,242 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 15,403 | 17,285 | 20,120 | 22,381 | 14,405 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15,403 | 17,285 | 20,120 | 22,381 | 14,405 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 16 | 18.1 | 21.2 | 23.9 | 24.1 |
Dividends per Share |